Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
We investigated the effect of tenascin-C(TNC), a matricellular protein, on pathophysiology of early brain injury after experimental subarachnoid hemorrhage(SAH) by using rats and mice endovascular perforation models. Firstly, we showed that SAH caused neuronal apoptosis in the brain with TNC upregulation. Next, we showed that intracisternally injected recombinant TNC reversed the anti-apoptotic effects in brain by imatinib. Lastly, using various inhibitors, we showed that early brain injury was improved with inhibition of TNC upregulation by supression of MAP kinase-dependent MMP-9 induction.
|